Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 8
Submit an article Journal homepage
352
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Combining blinatumomab with targeted therapy for BCR-ABL mutant relapsed/refractory acute lymphoblastic leukemia

Ahmad HanifDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; View further author information
,
Eunice S. WangLeukemia Service, Roswell Park Cancer Institute, Buffalo, NY, USAView further author information
,
James E. ThompsonLeukemia Service, Roswell Park Cancer Institute, Buffalo, NY, USAView further author information
,
Jeffrey I. BaronLeukemia Service, Roswell Park Cancer Institute, Buffalo, NY, USAView further author information
,
Mark D. WalshLeukemia Service, Roswell Park Cancer Institute, Buffalo, NY, USAView further author information
&
Elizabeth A. GriffithsLeukemia Service, Roswell Park Cancer Institute, Buffalo, NY, USACorrespondence[email protected]
View further author information
Pages 2011-2013 | Received 07 Sep 2017, Accepted 26 Nov 2017, Published online: 18 Dec 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1411595.

Additional information

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.